bxp inc. - BXP
BXP
Close Chg Chg %
76.22 -0.75 -0.98%
Closed Market
75.47
-0.75 (0.98%)
Volume: 2.84M
Last Updated:
Sep 24, 2025, 3:59 PM EDT
Company Overview: bxp inc. - BXP
BXP Key Data
Open $75.51 | Day Range 74.85 - 76.24 |
52 Week Range 54.22 - 90.11 | Market Cap $12.07B |
Shares Outstanding 158.38M | Public Float 157.73M |
Beta 1.24 | Rev. Per Employee N/A |
P/E Ratio 3,847.98 | EPS $0.02 |
Yield 514.50% | Dividend $0.70 |
EX-DIVIDEND DATE Sep 30, 2025 | SHORT INTEREST N/A |
AVERAGE VOLUME 2.09M |
BXP Performance
1 Week | -1.28% | ||
1 Month | 8.78% | ||
3 Months | 10.00% | ||
1 Year | -6.57% | ||
5 Years | -6.12% |
BXP Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
22
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
Average Recommendation | OVERWEIGHT | Average Target Price | 77.471 | |
Number of Ratings | 22 | Current Quarters Estimate | 0.452 | |
FY Report Date | 09 / 2025 | Current Year's Estimate | 1.847 | |
Last Quarter’s Earnings | 0.56 | Median PE on CY Estimate | N/A | |
Year Ago Earnings | 0.09 | Next Fiscal Year Estimate | 1.936 | |
Median PE on Next FY Estimate | N/A |
Earnings Per Share
This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
---|---|---|---|---|
# of Estimates | 5 | 5 | 5 | 5 |
Mean Estimate | 0.45 | 0.53 | 1.85 | 1.94 |
High Estimates | 0.54 | 0.57 | 1.97 | 2.28 |
Low Estimate | 0.40 | 0.45 | 1.59 | 1.63 |
Coefficient of Variance | 12.05 | 10.15 | 8.28 | 12.11 |
Analysts Recommendations
Current | 1 Month Ago | 3 Months Ago | |
---|---|---|---|
BUY | 6 | 8 | 8 |
OVERWEIGHT | 1 | 1 | 0 |
HOLD | 15 | 13 | 12 |
UNDERWEIGHT | 0 | 0 | 0 |
SELL | 0 | 0 | 1 |
MEAN | Overweight | Overweight | Overweight |
SEC Filings for Bxp Inc. - BXP
Filing Date | Type | Category | Amended |
---|---|---|---|
No results |
Insider Actions for Bxp Inc. - BXP
Date | Name | Shares | Transaction | Value |
---|---|---|---|---|
Aug 8, 2025 | John J. Stroman Executive Vice President | 16,838 | Conversion of derivative security | 0.00 |
Aug 8, 2025 | John J. Stroman Executive Vice President of GP | N/A | Conversion of derivative security | 0.00 |
Aug 8, 2025 | John J. Stroman Executive Vice President of GP | 51,351 | Conversion of derivative security | 0.00 |
Jul 2, 2025 | William H Walton Director | 8,252 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Jul 2, 2025 | Bruce W. Duncan Director | 11,192 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Jul 2, 2025 | Matthew J. Lustig Director | 18,714 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Jul 2, 2025 | Julie G. Richardson Director | 162 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Jul 2, 2025 | Mary E. Kipp Director | 6,401 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Jul 2, 2025 | Joel Irwin Klein Director | 21,136 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Jul 2, 2025 | Derek Anthony West Director | 3,142 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Apr 2, 2025 | Carol B. Einiger Director | 32,435 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 7, 2025 | Donna D. Garesche EVP, Chief HR Officer | N/A | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $67.87 per share | 0.00 |
Oct 2, 2024 | Tony West Director | 2,023 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |